Because of the structural similarities of LOX-5 and LOX-12 [12], this peptide (YWCS) functions as an inhibitor of both LOX isoforms and also acts as a dual inhibitor in breast cancer patients as well as in AD sufferers. The gene discussed is LOX; the disease is Alzheimer disease.